| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | 3-chloroallyl aldehyde dehydrogenase activity | 5.13e-07 | 7 | 50 | 3 | GO:0004028 | |
| GeneOntologyMolecularFunction | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity | 1.23e-06 | 9 | 50 | 3 | GO:0043878 | |
| GeneOntologyMolecularFunction | aldehyde dehydrogenase (NAD+) activity | 6.58e-06 | 15 | 50 | 3 | GO:0004029 | |
| GeneOntologyMolecularFunction | aldehyde dehydrogenase [NAD(P)+] activity | 9.80e-06 | 17 | 50 | 3 | GO:0004030 | |
| GeneOntologyMolecularFunction | transforming growth factor beta receptor binding | 6.32e-05 | 31 | 50 | 3 | GO:0005160 | |
| GeneOntologyMolecularFunction | diacylglycerol O-acyltransferase activity | 1.70e-04 | 8 | 50 | 2 | GO:0004144 | |
| GeneOntologyMolecularFunction | 2-acylglycerol O-acyltransferase activity | 1.70e-04 | 8 | 50 | 2 | GO:0003846 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor | 2.36e-04 | 48 | 50 | 3 | GO:0016620 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the aldehyde or oxo group of donors | 3.73e-04 | 56 | 50 | 3 | GO:0016903 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides | 7.21e-04 | 16 | 50 | 2 | GO:0016812 | |
| GeneOntologyMolecularFunction | SMAD binding | 1.31e-03 | 86 | 50 | 3 | GO:0046332 | |
| GeneOntologyMolecularFunction | D-glucose transmembrane transporter activity | 1.78e-03 | 25 | 50 | 2 | GO:0055056 | |
| GeneOntologyMolecularFunction | hexose transmembrane transporter activity | 1.78e-03 | 25 | 50 | 2 | GO:0015149 | |
| GeneOntologyMolecularFunction | monosaccharide transmembrane transporter activity | 2.07e-03 | 27 | 50 | 2 | GO:0015145 | |
| GeneOntologyMolecularFunction | NAD+-protein poly-ADP-ribosyltransferase activity | 2.23e-03 | 28 | 50 | 2 | GO:0003950 | |
| GeneOntologyMolecularFunction | sugar transmembrane transporter activity | 2.39e-03 | 29 | 50 | 2 | GO:0051119 | |
| GeneOntologyMolecularFunction | NAD+-protein ADP-ribosyltransferase activity | 2.56e-03 | 30 | 50 | 2 | GO:1990404 | |
| GeneOntologyMolecularFunction | acylglycerol O-acyltransferase activity | 2.91e-03 | 32 | 50 | 2 | GO:0016411 | |
| GeneOntologyMolecularFunction | carbohydrate transmembrane transporter activity | 4.96e-03 | 42 | 50 | 2 | GO:0015144 | |
| GeneOntologyMolecularFunction | glycosyltransferase activity | 5.80e-03 | 288 | 50 | 4 | GO:0016757 | |
| GeneOntologyBiologicalProcess | primary alcohol metabolic process | 5.75e-06 | 106 | 50 | 5 | GO:0034308 | |
| GeneOntologyBiologicalProcess | cellular response to oleic acid | 1.73e-05 | 3 | 50 | 2 | GO:0071400 | |
| GeneOntologyBiologicalProcess | response to oleic acid | 5.73e-05 | 5 | 50 | 2 | GO:0034201 | |
| GeneOntologyBiologicalProcess | aldehyde metabolic process | 8.27e-05 | 95 | 50 | 4 | GO:0006081 | |
| GeneOntologyBiologicalProcess | cellular catabolic process | KLHL3 CYP1B1 ADHFE1 ATP6V0B SMURF1 AMDHD1 NIPSNAP2 ZNRF1 CPS1 ALDH3B1 ALDH3B2 | 1.65e-04 | 1253 | 50 | 11 | GO:0044248 |
| GeneOntologyBiologicalProcess | diacylglycerol biosynthetic process | 2.56e-04 | 10 | 50 | 2 | GO:0006651 | |
| GeneOntologyBiologicalProcess | protein poly-ADP-ribosylation | 3.12e-04 | 11 | 50 | 2 | GO:0070212 | |
| GeneOntologyBiologicalProcess | protein auto-ADP-ribosylation | 3.12e-04 | 11 | 50 | 2 | GO:0070213 | |
| GeneOntologyBiologicalProcess | membrane lipid catabolic process | 3.22e-04 | 55 | 50 | 3 | GO:0046466 | |
| Domain | Aldehyde_DH_NAD(P) | 6.78e-08 | 4 | 49 | 3 | IPR012394 | |
| Domain | Calcineurin-like_Pesterase | 6.74e-06 | 2 | 49 | 2 | IPR024201 | |
| Domain | Ald_DH_CS_GLU | 9.28e-06 | 16 | 49 | 3 | IPR029510 | |
| Domain | Ald_DH_CS_CYS | 1.12e-05 | 17 | 49 | 3 | IPR016160 | |
| Domain | ALDEHYDE_DEHYDR_GLU | 1.35e-05 | 18 | 49 | 3 | PS00687 | |
| Domain | ALDEHYDE_DEHYDR_CYS | 1.35e-05 | 18 | 49 | 3 | PS00070 | |
| Domain | - | 1.60e-05 | 19 | 49 | 3 | 3.40.605.10 | |
| Domain | Aldedh | 1.60e-05 | 19 | 49 | 3 | PF00171 | |
| Domain | Aldehyde_DH_dom | 1.60e-05 | 19 | 49 | 3 | IPR015590 | |
| Domain | - | 1.60e-05 | 19 | 49 | 3 | 3.40.309.10 | |
| Domain | Ald_DH_C | 1.60e-05 | 19 | 49 | 3 | IPR016163 | |
| Domain | Ald_DH_N | 1.60e-05 | 19 | 49 | 3 | IPR016162 | |
| Domain | Ald_DH/histidinol_DH | 1.60e-05 | 19 | 49 | 3 | IPR016161 | |
| Domain | DAGAT | 1.40e-04 | 7 | 49 | 2 | PF03982 | |
| Domain | DAGAT | 1.40e-04 | 7 | 49 | 2 | IPR007130 | |
| Domain | Poly(ADP-ribose)pol_cat_dom | 8.94e-04 | 17 | 49 | 2 | IPR012317 | |
| Domain | PARP_CATALYTIC | 8.94e-04 | 17 | 49 | 2 | PS51059 | |
| Domain | PARP | 8.94e-04 | 17 | 49 | 2 | PF00644 | |
| Domain | - | 8.94e-04 | 17 | 49 | 2 | 3.90.228.10 | |
| Domain | WGR_domain | 1.79e-03 | 24 | 49 | 2 | IPR008893 | |
| Domain | HECT | 2.27e-03 | 27 | 49 | 2 | PF00632 | |
| Domain | HECTc | 2.27e-03 | 27 | 49 | 2 | SM00119 | |
| Domain | HECT_dom | 2.27e-03 | 27 | 49 | 2 | IPR000569 | |
| Domain | HECT | 2.27e-03 | 27 | 49 | 2 | PS50237 | |
| Domain | Calcineurin-like_PHP_ApaH | 2.44e-03 | 28 | 49 | 2 | IPR004843 | |
| Domain | Metallophos | 2.44e-03 | 28 | 49 | 2 | PF00149 | |
| Domain | Metallo-depent_PP-like | 2.80e-03 | 30 | 49 | 2 | IPR029052 | |
| Domain | - | 2.80e-03 | 30 | 49 | 2 | 3.60.21.10 | |
| Domain | Abhydrolase_1 | 2.99e-03 | 31 | 49 | 2 | PF00561 | |
| Domain | AB_hydrolase_1 | 3.38e-03 | 33 | 49 | 2 | IPR000073 | |
| Domain | Gal_Oxidase_b-propeller | 3.59e-03 | 34 | 49 | 2 | IPR015916 | |
| Domain | SAM_2 | 5.69e-03 | 43 | 49 | 2 | PF07647 | |
| Domain | WW | 6.76e-03 | 47 | 49 | 2 | PF00397 | |
| Domain | WW | 7.04e-03 | 48 | 49 | 2 | SM00456 | |
| Domain | WW_DOMAIN_2 | 7.92e-03 | 51 | 49 | 2 | PS50020 | |
| Domain | WW_DOMAIN_1 | 7.92e-03 | 51 | 49 | 2 | PS01159 | |
| Domain | WW_dom | 8.22e-03 | 52 | 49 | 2 | IPR001202 | |
| Domain | USP_CS | 1.30e-02 | 66 | 49 | 2 | IPR018200 | |
| Pathway | KEGG_HISTIDINE_METABOLISM | 9.10e-07 | 29 | 37 | 4 | M12524 | |
| Pathway | REACTOME_SPHINGOLIPID_CATABOLISM | 3.60e-06 | 12 | 37 | 3 | M48264 | |
| Pathway | REACTOME_SPHINGOLIPID_CATABOLISM | 3.60e-06 | 12 | 37 | 3 | MM17238 | |
| Pathway | KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450 | 3.25e-05 | 70 | 37 | 4 | M16794 | |
| Pathway | REACTOME_DOWNREGULATION_OF_TGF_BETA_RECEPTOR_SIGNALING | 4.15e-05 | 26 | 37 | 3 | M628 | |
| Pathway | REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES | 1.33e-04 | 191 | 37 | 5 | MM15289 | |
| Pathway | REACTOME_TGF_BETA_RECEPTOR_SIGNALING_ACTIVATES_SMADS | 2.49e-04 | 47 | 37 | 3 | M646 | |
| Pathway | REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES | 2.62e-04 | 221 | 37 | 5 | M27578 | |
| Pathway | REACTOME_DEGRADATION_OF_AXIN | 3.56e-04 | 53 | 37 | 3 | MM15152 | |
| Pathway | REACTOME_DEGRADATION_OF_AXIN | 3.98e-04 | 55 | 37 | 3 | M27398 | |
| Pathway | BIOCARTA_VITCB_PATHWAY | 4.35e-04 | 12 | 37 | 2 | MM1526 | |
| Pathway | REACTOME_TRIGLYCERIDE_BIOSYNTHESIS | 4.35e-04 | 12 | 37 | 2 | MM15447 | |
| Pathway | KEGG_GLYCOLYSIS_GLUCONEOGENESIS | 5.66e-04 | 62 | 37 | 3 | M11521 | |
| Pathway | REACTOME_DEUBIQUITINATION | 5.72e-04 | 262 | 37 | 5 | MM15286 | |
| Pathway | REACTOME_TRIGLYCERIDE_BIOSYNTHESIS | 5.98e-04 | 14 | 37 | 2 | M619 | |
| Pathway | BIOCARTA_EFP_PATHWAY | 7.86e-04 | 16 | 37 | 2 | M22011 | |
| Pathway | KEGG_DRUG_METABOLISM_CYTOCHROME_P450 | 8.76e-04 | 72 | 37 | 3 | M9257 | |
| Pathway | KEGG_PHENYLALANINE_METABOLISM | 9.99e-04 | 18 | 37 | 2 | M16650 | |
| Pathway | REACTOME_DEUBIQUITINATION | 1.04e-03 | 299 | 37 | 5 | M27574 | |
| Pathway | REACTOME_CELLULAR_HEXOSE_TRANSPORT | 1.11e-03 | 19 | 37 | 2 | MM14718 | |
| Pathway | REACTOME_CELLULAR_HEXOSE_TRANSPORT | 1.36e-03 | 21 | 37 | 2 | M27058 | |
| Pathway | WP_NAD_BIOSYNTHETIC_PATHWAYS | 1.50e-03 | 22 | 37 | 2 | M39704 | |
| Pathway | REACTOME_TRIGLYCERIDE_METABOLISM | 1.64e-03 | 23 | 37 | 2 | MM15575 | |
| Pathway | WP_TRIACYLGLYCERIDE_SYNTHESIS | 1.64e-03 | 23 | 37 | 2 | MM15890 | |
| Pathway | REACTOME_SPHINGOLIPID_METABOLISM | 1.78e-03 | 92 | 37 | 3 | MM15086 | |
| Pathway | WP_TRIACYLGLYCERIDE_SYNTHESIS | 1.78e-03 | 24 | 37 | 2 | M39692 | |
| Pathway | REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX | 1.89e-03 | 94 | 37 | 3 | M1041 | |
| Pathway | KEGG_ASCORBATE_AND_ALDARATE_METABOLISM | 1.94e-03 | 25 | 37 | 2 | M605 | |
| Pathway | REACTOME_SPHINGOLIPID_METABOLISM | 2.74e-03 | 107 | 37 | 3 | M14857 | |
| Pathway | REACTOME_SIGNALING_BY_BMP | 2.97e-03 | 31 | 37 | 2 | M1662 | |
| Pathway | REACTOME_SIGNALING_BY_BMP | 2.97e-03 | 31 | 37 | 2 | MM14789 | |
| Pathway | REACTOME_SIGNALING_BY_WNT | 3.43e-03 | 239 | 37 | 4 | MM14756 | |
| Pathway | REACTOME_SIGNALING_BY_WNT_IN_CANCER | 3.57e-03 | 34 | 37 | 2 | M27405 | |
| Pathway | REACTOME_METABOLIC_DISORDERS_OF_BIOLOGICAL_OXIDATION_ENZYMES | 3.57e-03 | 34 | 37 | 2 | M27461 | |
| Pubmed | 1.19e-08 | 4 | 51 | 3 | 25286108 | ||
| Pubmed | 1.07e-06 | 14 | 51 | 3 | 35733260 | ||
| Pubmed | Tankyrase is necessary for canonical Wnt signaling during kidney development. | 2.11e-06 | 2 | 51 | 2 | 20549720 | |
| Pubmed | The 239AB gene on chromosome 22: a novel member of an ancient gene family. | 2.11e-06 | 2 | 51 | 2 | 9266672 | |
| Pubmed | Tankyrase 1 and tankyrase 2 are essential but redundant for mouse embryonic development. | 2.11e-06 | 2 | 51 | 2 | 18612384 | |
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 15795250 | ||
| Pubmed | Proteomic Analysis of the Human Tankyrase Protein Interaction Network Reveals Its Role in Pexophagy. | 2.11e-06 | 2 | 51 | 2 | 28723574 | |
| Pubmed | Tankyrase Requires SAM Domain-Dependent Polymerization to Support Wnt-β-Catenin Signaling. | 2.11e-06 | 2 | 51 | 2 | 27494558 | |
| Pubmed | Regulation of tankyrase activity by a catalytic domain dimer interface. | 2.11e-06 | 2 | 51 | 2 | 30055800 | |
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 11352564 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 34370553 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 31899247 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 8666403 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 18026951 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 18927080 | ||
| Pubmed | Structural insights into SAM domain-mediated tankyrase oligomerization. | 2.11e-06 | 2 | 51 | 2 | 27328430 | |
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 29263426 | ||
| Pubmed | Molecular insights on TNKS1/TNKS2 and inhibitor-IWR1 interactions. | 2.11e-06 | 2 | 51 | 2 | 24291818 | |
| Pubmed | Discovery of tankyrase inhibiting flavones with increased potency and isoenzyme selectivity. | 2.11e-06 | 2 | 51 | 2 | 24116873 | |
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 33090007 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 9161417 | ||
| Pubmed | Dissecting the molecular determinants of clinical PARP1 inhibitor selectivity for tankyrase1. | 6.32e-06 | 3 | 51 | 2 | 33361107 | |
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 32442396 | ||
| Pubmed | USP15 regulates SMURF2 kinetics through C-lobe mediated deubiquitination. | 6.32e-06 | 3 | 51 | 2 | 26435193 | |
| Pubmed | Role for the related poly(ADP-Ribose) polymerases tankyrase 1 and 2 at human telomeres. | 6.32e-06 | 3 | 51 | 2 | 11739745 | |
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 26246473 | ||
| Pubmed | Cloning of DGAT2, a second mammalian diacylglycerol acyltransferase, and related family members. | 6.32e-06 | 3 | 51 | 2 | 11481335 | |
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 25939383 | ||
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 37537194 | ||
| Pubmed | Tankyrase inhibition aggravates kidney injury in the absence of CD2AP. | 6.32e-06 | 3 | 51 | 2 | 27441654 | |
| Pubmed | The Smurf ubiquitin ligases regulate tissue separation via antagonistic interactions with ephrinB1. | 6.32e-06 | 3 | 51 | 2 | 23475958 | |
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 25051198 | ||
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 30244169 | ||
| Pubmed | Arpin Regulates Migration Persistence by Interacting with Both Tankyrases and the Arp2/3 Complex. | 6.32e-06 | 3 | 51 | 2 | 33923443 | |
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 15173588 | ||
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 11454873 | ||
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 21251231 | ||
| Pubmed | Requirement of Smurf-mediated endocytosis of Patched1 in sonic hedgehog signal reception. | 6.32e-06 | 3 | 51 | 2 | 24925320 | |
| Pubmed | TRAF4 promotes TGF-β receptor signaling and drives breast cancer metastasis. | 1.17e-05 | 30 | 51 | 3 | 23973329 | |
| Pubmed | Non-proteolytic ubiquitin modification of PPARγ by Smurf1 protects the liver from steatosis. | 1.26e-05 | 4 | 51 | 2 | 30566427 | |
| Pubmed | Tankyrases maintain homeostasis of intestinal epithelium by preventing cell death. | 1.26e-05 | 4 | 51 | 2 | 30260955 | |
| Pubmed | PARP5A and RNF146 phase separation restrains RIPK1-dependent necroptosis. | 1.26e-05 | 4 | 51 | 2 | 38272024 | |
| Pubmed | 1.26e-05 | 4 | 51 | 2 | 34370213 | ||
| Pubmed | 1.26e-05 | 4 | 51 | 2 | 26513298 | ||
| Pubmed | 1.26e-05 | 4 | 51 | 2 | 16373342 | ||
| Pubmed | 1.26e-05 | 4 | 51 | 2 | 36383218 | ||
| Pubmed | Identification of a novel human tankyrase through its interaction with the adaptor protein Grb14. | 1.26e-05 | 4 | 51 | 2 | 11278563 | |
| Pubmed | Nedd8 targets ubiquitin ligase Smurf2 for neddylation and promote its degradation. | 1.26e-05 | 4 | 51 | 2 | 27086113 | |
| Pubmed | 1.26e-05 | 4 | 51 | 2 | 11854288 | ||
| Pubmed | The WW1 Domain Enhances Autoinhibition in Smurf Ubiquitin Ligases. | 1.26e-05 | 4 | 51 | 2 | 31628949 | |
| Pubmed | 1.72e-05 | 34 | 51 | 3 | 15221005 | ||
| Pubmed | 2.10e-05 | 5 | 51 | 2 | 11802774 | ||
| Pubmed | 2.10e-05 | 5 | 51 | 2 | 28839186 | ||
| Pubmed | Impaired Smad7-Smurf-mediated negative regulation of TGF-beta signaling in scleroderma fibroblasts. | 2.10e-05 | 5 | 51 | 2 | 14722617 | |
| Pubmed | Pivotal role of the C2 domain of the Smurf1 ubiquitin ligase in substrate selection. | 2.10e-05 | 5 | 51 | 2 | 21402695 | |
| Pubmed | Tankyrase represses autoinflammation through the attenuation of TLR2 signaling. | 2.10e-05 | 5 | 51 | 2 | 35362478 | |
| Pubmed | 2.10e-05 | 5 | 51 | 2 | 28798345 | ||
| Pubmed | 2.10e-05 | 5 | 51 | 2 | 20937913 | ||
| Pubmed | Inhibition of HECT E3 ligases as potential therapy for COVID-19. | 2.10e-05 | 5 | 51 | 2 | 33762578 | |
| Pubmed | 2.10e-05 | 5 | 51 | 2 | 22473005 | ||
| Pubmed | Identification of a gene encoding MGAT1, a monoacylglycerol acyltransferase. | 2.10e-05 | 5 | 51 | 2 | 12077311 | |
| Pubmed | 3.15e-05 | 6 | 51 | 2 | 21897371 | ||
| Pubmed | Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling. | 3.15e-05 | 6 | 51 | 2 | 19759537 | |
| Pubmed | Ubiquitin ligase RNF146 regulates tankyrase and Axin to promote Wnt signaling. | 3.15e-05 | 6 | 51 | 2 | 21799911 | |
| Pubmed | 3.15e-05 | 6 | 51 | 2 | 28049720 | ||
| Pubmed | Tankyrases Promote Homologous Recombination and Check Point Activation in Response to DSBs. | 3.15e-05 | 6 | 51 | 2 | 26845027 | |
| Pubmed | 3.15e-05 | 6 | 51 | 2 | 19318350 | ||
| Pubmed | 3.15e-05 | 6 | 51 | 2 | 22921829 | ||
| Pubmed | Tankyrase regulates epithelial lumen formation via suppression of Rab11 GEFs. | 3.15e-05 | 6 | 51 | 2 | 34128958 | |
| Pubmed | 3.15e-05 | 6 | 51 | 2 | 32361710 | ||
| Pubmed | 3.15e-05 | 6 | 51 | 2 | 10988299 | ||
| Pubmed | 3.15e-05 | 6 | 51 | 2 | 23781096 | ||
| Pubmed | CHIP mediates degradation of Smad proteins and potentially regulates Smad-induced transcription. | 4.41e-05 | 7 | 51 | 2 | 14701756 | |
| Pubmed | 4.41e-05 | 7 | 51 | 2 | 30587574 | ||
| Pubmed | SET9-Mediated Regulation of TGF-β Signaling Links Protein Methylation to Pulmonary Fibrosis. | 4.41e-05 | 7 | 51 | 2 | 27292644 | |
| Pubmed | 4.41e-05 | 7 | 51 | 2 | 28169289 | ||
| Pubmed | Loss of Tankyrase-mediated destruction of 3BP2 is the underlying pathogenic mechanism of cherubism. | 4.41e-05 | 7 | 51 | 2 | 22153076 | |
| Pubmed | Poly-ADP ribosylation of PTEN by tankyrases promotes PTEN degradation and tumor growth. | 4.41e-05 | 7 | 51 | 2 | 25547115 | |
| Pubmed | 4.41e-05 | 7 | 51 | 2 | 31554794 | ||
| Pubmed | RNF146 is a poly(ADP-ribose)-directed E3 ligase that regulates axin degradation and Wnt signalling. | 4.41e-05 | 7 | 51 | 2 | 21478859 | |
| Pubmed | Genomic organization of the DGAT2/MOGAT gene family in cattle (Bos taurus) and other mammals. | 5.87e-05 | 8 | 51 | 2 | 14970677 | |
| Pubmed | A role for ubiquitin ligases and Spartin/SPG20 in lipid droplet turnover. | 5.87e-05 | 8 | 51 | 2 | 19307600 | |
| Pubmed | 5.87e-05 | 8 | 51 | 2 | 28881580 | ||
| Pubmed | 5.87e-05 | 8 | 51 | 2 | 22344298 | ||
| Pubmed | 5.87e-05 | 8 | 51 | 2 | 20484049 | ||
| Pubmed | Polymorphisms in telomere-associated genes, breast cancer susceptibility and prognosis. | 7.54e-05 | 9 | 51 | 2 | 19766477 | |
| Pubmed | 7.54e-05 | 9 | 51 | 2 | 12080061 | ||
| Pubmed | Formin 2 Regulates Lysosomal Degradation of Wnt-Associated β-Catenin in Neural Progenitors. | 7.54e-05 | 9 | 51 | 2 | 29659741 | |
| Pubmed | 9.42e-05 | 10 | 51 | 2 | 15221015 | ||
| Pubmed | 9.42e-05 | 10 | 51 | 2 | 25092867 | ||
| Pubmed | 9.42e-05 | 10 | 51 | 2 | 15138260 | ||
| Pubmed | 1.15e-04 | 11 | 51 | 2 | 17996703 | ||
| Pubmed | 1.15e-04 | 11 | 51 | 2 | 22773947 | ||
| Pubmed | 1.15e-04 | 11 | 51 | 2 | 28963376 | ||
| Pubmed | 1.15e-04 | 11 | 51 | 2 | 20937264 | ||
| Pubmed | NEDD4 E3 ligase inhibits the activity of the Hippo pathway by targeting LATS1 for degradation. | 1.38e-04 | 12 | 51 | 2 | 24107629 | |
| Pubmed | 1.87e-04 | 193 | 51 | 4 | 19343046 | ||
| Pubmed | 1.90e-04 | 14 | 51 | 2 | 21791611 | ||
| Pubmed | 1.90e-04 | 14 | 51 | 2 | 26147758 | ||
| Pubmed | Identifying the ubiquitination targets of E6AP by orthogonal ubiquitin transfer. | 1.90e-04 | 14 | 51 | 2 | 29263404 | |
| Interaction | AXIN1 interactions | 2.63e-06 | 166 | 48 | 6 | int:AXIN1 | |
| GeneFamily | Aldehyde dehydrogenases | 4.34e-06 | 19 | 31 | 3 | 398 | |
| GeneFamily | Diacylglycerol O-acyltransferase 2 family | 7.92e-05 | 8 | 31 | 2 | 1235 | |
| GeneFamily | Zinc fingers|Zinc fingers PARP-type|Poly(ADP-ribose) polymerases | 3.81e-04 | 17 | 31 | 2 | 684 | |
| GeneFamily | Ubiquitin specific peptidases | 4.14e-03 | 56 | 31 | 2 | 366 | |
| GeneFamily | Sterile alpha motif domain containing | 9.94e-03 | 88 | 31 | 2 | 760 | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Peri/Epineurial_-NAF_endoneurial|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 6.76e-07 | 145 | 51 | 5 | e808502fa52baf1c400f3c9b918a167127e78af9 | |
| Computational | Oxidoreductases. | 9.38e-06 | 14 | 33 | 3 | MODULE_464 | |
| Computational | Genes in the cancer module 194. | 1.17e-05 | 15 | 33 | 3 | MODULE_194 | |
| Computational | Oxidoreductases. | 3.90e-05 | 22 | 33 | 3 | MODULE_373 | |
| Drug | methylimidazole acetaldehyde | 4.41e-08 | 17 | 49 | 4 | CID000193545 | |
| Drug | hydroxyl radicals | USP44 CYP1B1 ADHFE1 ATP6V0B MOGAT1 DGAT2 AMDHD1 PDP2 CPS1 ALDH3B1 ALDH3B2 ALDH3A2 USP15 OPLAH | 5.44e-07 | 1341 | 49 | 14 | CID000000961 |
| Drug | hydride | CYP1B1 ADHFE1 ATP6V0B SLC4A8 TNKS CPS1 ALDH3B1 TNKS2 ALDH3B2 ALDH3A2 SLC5A2 | 1.23e-06 | 835 | 49 | 11 | CID000000783 |
| Drug | trichloroacetic acid | 3.37e-06 | 107 | 49 | 5 | CID000006421 | |
| Drug | propionaldehyde | 4.39e-06 | 51 | 49 | 4 | CID000000527 | |
| Drug | 5-methylnicotinamide | 5.14e-06 | 16 | 49 | 3 | CID000065560 | |
| Drug | chloral hydrate | 8.43e-06 | 129 | 49 | 5 | CID000002707 | |
| Drug | dhmal | 3.29e-05 | 29 | 49 | 3 | CID000151725 | |
| Drug | dithiotreitol | 3.54e-05 | 430 | 49 | 7 | CID000019001 | |
| Drug | 3,4-dihydroxyphenylacetaldehyde | 3.65e-05 | 30 | 49 | 3 | CID000119219 | |
| Drug | coenzyme 1 | 3.68e-05 | 596 | 49 | 8 | CID000000925 | |
| Drug | CoA group | 3.70e-05 | 433 | 49 | 7 | CID000000317 | |
| Drug | 3-chlorobenzyl alcohol | 4.52e-05 | 5 | 49 | 2 | CID000070117 | |
| Drug | Apomorphine hydrochloride hemihydrate [41372-20-7]; Up 200; 6.4uM; MCF7; HT_HG-U133A | 6.30e-05 | 196 | 49 | 5 | 1505_UP | |
| Drug | phenylacetaldehyde | 6.38e-05 | 100 | 49 | 4 | CID000000998 | |
| Drug | 4-hydroxy-3-methoxymandelaldehyde | 6.77e-05 | 6 | 49 | 2 | CID000440729 | |
| Drug | octanal | 6.91e-05 | 37 | 49 | 3 | CID000000454 | |
| Drug | IEM-611 | 9.46e-05 | 7 | 49 | 2 | CID000039794 | |
| Drug | butoxyacetaldehyde | 9.46e-05 | 7 | 49 | 2 | CID000114858 | |
| Drug | phenobarbital | 1.18e-04 | 360 | 49 | 6 | CID000004763 | |
| Drug | 20-CHO-LTB4 | 1.26e-04 | 8 | 49 | 2 | CID006449839 | |
| Drug | homovanillin | 1.26e-04 | 8 | 49 | 2 | CID000151276 | |
| Drug | DL-1,2-anhydro-myo-inositol | 1.33e-04 | 46 | 49 | 3 | CID000002859 | |
| Disease | Sjogren-Larsson syndrome (implicated_via_orthology) | 9.12e-08 | 6 | 50 | 3 | DOID:14501 (implicated_via_orthology) | |
| Disease | vitamin D measurement | 2.59e-04 | 336 | 50 | 5 | EFO_0004631 | |
| Disease | serine measurement, amino acid measurement | 3.77e-04 | 17 | 50 | 2 | EFO_0005134, EFO_0009774 | |
| Disease | Impaired glucose tolerance | 8.23e-04 | 25 | 50 | 2 | C0271650 | |
| Disease | macular telangiectasia type 2 | 8.91e-04 | 26 | 50 | 2 | EFO_1002009 | |
| Disease | serine measurement | 1.62e-03 | 35 | 50 | 2 | EFO_0009774 | |
| Disease | kynurenine measurement | 2.00e-03 | 39 | 50 | 2 | EFO_0008529 | |
| Disease | triglyceride measurement, low density lipoprotein cholesterol measurement | 2.82e-03 | 166 | 50 | 3 | EFO_0004530, EFO_0004611 | |
| Disease | apolipoprotein A 1 measurement | 3.00e-03 | 848 | 50 | 6 | EFO_0004614 | |
| Disease | cognitive inhibition measurement | 3.27e-03 | 50 | 50 | 2 | EFO_0007969 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| YSFLMHTAAGAEGGG | 1601 | Q14031 | |
| GASGMGRYHGKFSFD | 406 | P43353 | |
| HAAGSHGVSGIFMKY | 281 | Q96RQ1 | |
| GMGAYHGKHSFDTFS | 406 | P51648 | |
| FGGVGHSGMGRYHGK | 321 | P48448 | |
| RVMGKGHQHYGFGGE | 86 | Q8N865 | |
| KLMTYFGHFGGANHA | 436 | Q9HA90 | |
| GGFFSQIGQLYMVHH | 221 | O75323 | |
| HSAVAMGKHVYIFGG | 246 | Q7Z6M1 | |
| GSYVVGFAGAMAHTG | 146 | Q96RC9 | |
| MHGHGIGRFSEEEIY | 246 | Q5TGI0 | |
| FGFHPHGIMAVGAFG | 106 | Q96PD6 | |
| KLHVFGGIHEGYGIM | 246 | Q15777 | |
| SHFAMMHGGTGFAGI | 246 | Q15365 | |
| HSEYELAIAGMFGGF | 241 | Q9HA64 | |
| GELEMGHGGTHGFGY | 1731 | E2RYF6 | |
| DSGFTHGHMGYVFSK | 791 | Q14432 | |
| HYFGVGGGVHLFQKF | 326 | O95568 | |
| HGDFLFTGHMHFGEA | 266 | Q641Q3 | |
| VFGHIHEGYGVMADG | 281 | O15442 | |
| MEFHNGGHVSGIGGF | 1 | Q8TDB8 | |
| MFGIFDGHGGHACAQ | 136 | Q9P2J9 | |
| FDDHGMMVLGCGPYH | 971 | P31327 | |
| SMLYHHHGVGQGFSG | 361 | Q04446 | |
| MGYHGQGPSDHYRSF | 1751 | O14647 | |
| HYFNMIEGQGHGAVF | 506 | Q9NSI6 | |
| GATYMEIHQAGGGIH | 106 | Q96NU7 | |
| GVVFMAGHVYAVGGF | 341 | Q9UH77 | |
| VSGGRSMAFGHYSEH | 126 | Q16678 | |
| YVAMDFGGHGLSSHY | 61 | Q9H4I8 | |
| YIFGYHPHGIMGLGA | 156 | Q96PD7 | |
| FGNAGVHLCHGMSYP | 321 | Q8IWW8 | |
| YVAMDFGGHGLSSHY | 61 | Q9NQF3 | |
| GAGFLELHPYMFHGG | 1721 | O75445 | |
| LAGEYFHKAAQGGHM | 821 | Q68CR1 | |
| NAHMGYYETVAGGAG | 1111 | O14841 | |
| GLHEIGHGSFGAVYF | 26 | Q9H2K8 | |
| HGEFMGSACGHHGPY | 676 | Q2Y0W8 | |
| GSGFHFHLYLMHKGG | 201 | P0DPD7 | |
| FVGRIMGLAVFHGHY | 491 | Q9HCE7 | |
| MGLAVFHGHYINGGF | 496 | Q9HCE7 | |
| GMAVFHGHYIDGGFT | 491 | Q9HAU4 | |
| GACILMGYAFHEVGG | 211 | P31639 | |
| MGYAFHEVGGYSGLF | 216 | P31639 | |
| GFDERHAYIGGMFGA | 1196 | O95271 | |
| HAYIGGMFGAGIYFA | 1201 | O95271 | |
| YHAGYSMFGAGLTVG | 131 | Q99437 | |
| SNHYGGMGGGHYTAF | 881 | Q9Y4E8 | |
| HKGFDERHAYIGGMF | 1041 | Q9H2K2 | |
| PFQCGGAHYSHGDSM | 206 | E7ETH6 | |
| THGGMNGIYEAIYHG | 371 | Q6UWM9 | |
| GGFVLVHAGAGYHSE | 41 | Q9H6P5 | |
| MHHGKGFGSGHYTAY | 626 | Q9H0E7 | |
| APHFGHYRTGGGAMG | 31 | Q8ND25 | |
| HGFGQLMFADGGTYL | 26 | Q8NDC4 |